Mitchell Kapoor
Stock Analyst at H.C. Wainwright
(4.44)
# 1,113
Out of 4,407 analysts
692
Total ratings
42.3%
Success rate
10.2%
Average return
Main Sectors:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMRA Damora Therapeutics | Initiated Coverage: Buy | $45 | $20.78 | +116.55% | 1 | Jun 11, 2026 | |
| INCY Incyte | Reiterated: Buy | $135 → $140 | $108.53 | +29.00% | 11 | Jun 10, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $70 | $29.10 | +140.55% | 33 | Jun 9, 2026 | |
| LYEL Lyell Immunopharma | Reiterated: Buy | $45 | $13.52 | +232.84% | 24 | Jun 9, 2026 | |
| KYTX Kyverna Therapeutics | Reiterated: Buy | $25 | $8.06 | +210.37% | 20 | Jun 4, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $120 | $69.89 | +71.70% | 16 | Jun 3, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $50 → $65 | $35.87 | +81.21% | 60 | Jun 3, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $125 | $73.28 | +70.59% | 25 | Jun 1, 2026 | |
| CBIO Crescent Biopharma | Downgraded: Hold | n/a | $17.92 | - | 7 | Jun 1, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $14.01 | - | 31 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 550.00 | $439.20 | +25.23% | 3 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.50 | +100.00% | 9 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $9.51 | +162.88% | 23 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.59 | +108.55% | 3 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $11.61 | +29.20% | 22 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.25 | +122.22% | 28 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $19.83 | +152.14% | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $50 | $55.95 | -10.63% | 8 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 | $24.15 | +3.52% | 22 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $35 | $14.76 | +137.13% | 7 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $26.99 | +66.73% | 35 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.71 | +309.36% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $25 | $12.11 | +106.44% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $69.50 | +36.69% | 56 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $3.01 | +265.45% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $15.31 | -67.34% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $25 | $12.38 | +101.94% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $49.80 | +60.64% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $4.37 | +128.83% | 16 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.92 | - | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.41 | +183.69% | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.20 | +483.33% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $3.70 | -45.95% | 9 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $5.93 | +321.59% | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.92 | n/a | 26 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0061 | n/a | 16 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.7601 | n/a | 24 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $5.53 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $4.20 | n/a | 6 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $61 | $0.0127 | n/a | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.04 | n/a | 8 | Aug 11, 2023 |
Damora Therapeutics
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $20.78
Upside: +116.55%
Incyte
Jun 10, 2026
Reiterated: Buy
Price Target: $135 → $140
Current: $108.53
Upside: +29.00%
Neurogene
Jun 9, 2026
Reiterated: Buy
Price Target: $70
Current: $29.10
Upside: +140.55%
Lyell Immunopharma
Jun 9, 2026
Reiterated: Buy
Price Target: $45
Current: $13.52
Upside: +232.84%
Kyverna Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $25
Current: $8.06
Upside: +210.37%
Oruka Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: $120
Current: $69.89
Upside: +71.70%
Legend Biotech
Jun 3, 2026
Reiterated: Buy
Price Target: $50 → $65
Current: $35.87
Upside: +81.21%
Ionis Pharmaceuticals
Jun 1, 2026
Reiterated: Buy
Price Target: $125
Current: $73.28
Upside: +70.59%
Crescent Biopharma
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $17.92
Upside: -
Summit Therapeutics
Jun 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.01
Upside: -
May 27, 2026
Reiterated: Buy
Price Target: kr 550.00
Current: $439.20
Upside: +25.23%
May 26, 2026
Reiterated: Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
May 26, 2026
Maintained: Buy
Price Target: $25
Current: $9.51
Upside: +162.88%
May 26, 2026
Reiterated: Buy
Price Target: $20
Current: $9.59
Upside: +108.55%
May 26, 2026
Maintained: Buy
Price Target: $15
Current: $11.61
Upside: +29.20%
May 26, 2026
Reiterated: Buy
Price Target: $5
Current: $2.25
Upside: +122.22%
May 26, 2026
Reiterated: Buy
Price Target: $50
Current: $19.83
Upside: +152.14%
May 22, 2026
Reiterated: Hold
Price Target: $55 → $50
Current: $55.95
Upside: -10.63%
May 15, 2026
Downgraded: Hold
Price Target: $25
Current: $24.15
Upside: +3.52%
May 14, 2026
Reiterated: Buy
Price Target: $40 → $35
Current: $14.76
Upside: +137.13%
May 14, 2026
Reiterated: Buy
Price Target: $45
Current: $26.99
Upside: +66.73%
May 13, 2026
Reiterated: Buy
Price Target: $7
Current: $1.71
Upside: +309.36%
May 13, 2026
Reiterated: Buy
Price Target: $30 → $25
Current: $12.11
Upside: +106.44%
May 12, 2026
Reiterated: Buy
Price Target: $95
Current: $69.50
Upside: +36.69%
May 11, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $3.01
Upside: +265.45%
May 8, 2026
Reiterated: Sell
Price Target: $5
Current: $15.31
Upside: -67.34%
May 8, 2026
Rated: Buy
Price Target: $16 → $25
Current: $12.38
Upside: +101.94%
May 5, 2026
Reiterated: Buy
Price Target: $80
Current: $49.80
Upside: +60.64%
Jan 13, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $4.37
Upside: +128.83%
Jan 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.92
Upside: -
Oct 24, 2025
Reiterated: Buy
Price Target: $4
Current: $1.41
Upside: +183.69%
Oct 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.20
Upside: +483.33%
Aug 19, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $3.70
Upside: -45.95%
Aug 11, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $5.93
Upside: +321.59%
Apr 30, 2025
Rated: Hold
Price Target: n/a
Current: $15.92
Upside: n/a
Apr 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.0061
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $9
Current: $0.7601
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $15
Current: $5.53
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $15
Current: $4.20
Upside: n/a
Sep 6, 2023
Reiterated: Buy
Price Target: $160 → $61
Current: $0.0127
Upside: n/a
Aug 11, 2023
Reiterated: Hold
Price Target: n/a
Current: $2.04
Upside: n/a